The Italian life sciences ecosystem has entered a period of profound structural transformation, transitioning from a cluster of high-quality specialized manufacturers into a primary engine of European medical innovation. Historically recognized as the fourth-largest medical device market in Europe, Italy is now characterized by a surge in venture capital activity, strategic international partnerships, and a regulatory environment that is increasingly favorable to high-growth